Devil in reform detail
December 15, 2015
Australian Self Medication
Industry (ASMI) representatives
Annaliese Scholz and Steve Scarff
participated in a Department
of Health stakeholder forum
examining the complementary
medicines (CM) section
of the recently published
recommendations from the Review
of Medicines and Medical Devices
Regulation.
Three members of the Expert
Review Panel, representatives from
industry, members of academia,
professional groups, consumer
groups and the Therapeutic Goods
Administration also participated.
Emeritus Professor Lloyd Sansom
AO lead the discussion and ASMI
said there was “open, frank and
robust discussion” but all agreed
“the devil would be in the detail”
such as efficacy monographs,
revised listing pathways and other
regulatory frameworks’ roles.
Of particular interest to ASMI are
the Panel’s recommendations on
one complaints around advertising.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Dec 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Dec 15
